Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in non-small cell lung cancer (NSCLC) patients with ECOG performance status 2.

被引:0
|
作者
Giner, V.
Juan Vidal, O.
Munoz, J., Sr.
Esquerdo, G.
Sanchez-Hernandez, A.
Gomez-Codina, J.
Aparisi, F.
Macia, S.
Lopez Jimenez, A.
Catot, S.
机构
[1] Hosp Sagunto, Puerto Sangunto, Spain
[2] Hosp Arnau Vilanova, Valencia, Spain
[3] Hosp Doctor Peset, Valencia, Spain
[4] Hosp Clin Benidorm, Benidorm, Spain
[5] Hosp Prov Castellon, Castellon de La Plana, Spain
[6] Hosp La Fe, E-46009 Valencia, Spain
[7] Hosp Virgen de los Lirios, Alcoy, Spain
[8] Hosp Gen Elda, Elda, Spain
[9] Hosp Clin San Juan, Alicante, Spain
[10] Hosp Althaia Xarxa, Manresa, Spain
关键词
D O I
10.1200/jco.2010.28.15_suppl.e18083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18083
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients.
    Llorca, C.
    Esquerdo, G.
    Munoz, J., Sr.
    Sanchez-Hernandez, A.
    Gomez-Codina, J.
    Juan Vidal, O.
    Macia, S.
    Catot, S.
    Giner, V.
    Aparisi, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Phase II study of biweekly Gemcitabine and Docetaxel as first line treatment for advanced disease in elderly Non Small Cell Lung Cancer (NSCLC) patients
    Munoz-Langa, Jose
    Sanchez-Hernandez, Alfredo
    Gomez-Codina, Jose
    Esquerdo, Gaspar
    Catot, Silvia
    Macia, Sonia
    Juan, Oscar
    Giner, Vicente
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S700 - S701
  • [3] BIWEEKLY DOCETAXEL AS FIRST-LINE THERAPY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND PERFORMANCE STATUS (PS) 2. A PHASE II STUDY OF THE GALICIAN LUNG CANCER GROUP
    Leon, L.
    Vazquez Estevez, S.
    Firvida, J. L.
    Casal, J.
    Garcia, J.
    Salgado, M.
    Huidobro, G.
    Vazquez, F.
    Perez, E.
    Baron, F.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 95 - 95
  • [4] Biweekly docetaxel as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) 2: A phase II study of the Galician Lung Cancer Group
    Vazquez-Estevez, S.
    Leon, L.
    Firvida, J. L.
    Grande, C.
    Vazquez, F.
    Salgado, M.
    Casal, J.
    Baron, F. J.
    Abal, J.
    Garcia, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Biweekly docetaxel and carboplatin as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC). Finally results of a phase II study
    Firvida, J. L.
    Esquerdo, G.
    Amenedo, M.
    Salgado, M.
    LLorca, C.
    Perez, E.
    Cervera Grau, J.
    Ramos, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] BIWEEKLY CISPLATIN AND GEMCITABINE AS FIRST-LINE TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER
    Benekli, Mustafa
    Gunaydin, Yusuf
    Inanc, Mevlude
    Ozkan, Metin
    Demirci, Ayse
    Demirci, Umut
    Suner, Ali
    Karaca, Halit
    Tonyali, Onder
    Berk, Veli
    Buyukberber, Suleyman
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S563 - S563
  • [8] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [9] Phase II study of meloxicam with carboplatin plus docetaxel in first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)
    Ishida, T.
    Kanazawa, K.
    Oizumi, H.
    Yokouchi, H.
    Yamazaki, K.
    Akie, K.
    Sukoh, N.
    Harada, M.
    Munakata, M.
    Isobe, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: A phase II study
    Syrigos, K. N.
    Karapanagiotou, E.
    Charpidou, A.
    Dilana, K.
    Dannos, I.
    Dionellis, G.
    Rigopoulou, A.
    Georgatou, N.
    Roussos, C.
    [J]. JOURNAL OF CHEMOTHERAPY, 2007, 19 (04) : 438 - 443